Bio-Techne Corp (TECH) Company Profile & Statistics

Bio-Techne Corp
TECH
(Nasdaq - US)
Closed
62.81
+0.69 (+1.11%)
in:usd•As of: Apr 22, 2024 15:59 UTC -4
Open
62.33
High
63.39
Low
61.80

About Bio-Techne Corp

CEO

Charles R. Kummeth

Headquarters

614 mckinley place ne

minneapolis, mn 55413, united states

Auditor

KPMG LLP

Employees

3,050

Share Holders

140

Website

www.bio techne.com

Industry

biotechnology

Sector

health technology

Company Overview

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.

Bio-Techne Corp Statistics

Valuation Measures

Market Capitalization ²	9.87B
Enterprise Value	10.19B
Enterprise Value/EBITDA (ttm)	26.90
Price to Earnings Ratio (ttm)	36.33
Price to Book (mrq)	5.00
Price to Sales (ttm)	8.53
Price to Cash (ytd)	24.69

Profitability

Gross Margin (ttm)	67.08%
Operating Margin (ttm)	24.25%
Profit Margin (ttm)	19.35%
Return on Equity (ttm)	14.21%
Return on Invested Capital (ttm)	9.60%
Return on Assets (ttm)	10.36%

Income Statement

Revenue (ttm)	1.14B
Revenue Per Share (ttm)	7.28
Gross Profit (ttm)	768.64M
EBITDA (ttm)³	378.84M
Net Income Avi to Common (ttm)	224.16M
Diluted EPS (ttm)	1.38

Share Statistics

Beta (5Y Monthly)	1.22
52-Week Change	-24.98%
S&P500 52-Week Change	21.12%
S&P500 Member	Yes
Stock Optionable	Yes
Total Shares Outstanding ¹	157.19M
Dividend Yield	0.52%
Float ⁴	150.75M
% Held by Insiders	4.10%
% Held by Institutions	98.95%

Balance Sheet

Total Cash (mrq)	135.65M
Total Cash Per Share (mrq)	0.86
Total Debt (mrq)	447.00M
Total Debt/Equity (mrq)	22.76%
Current Ratio (mrq)	4.37%
Quick Ratio (mrq)	3.03%
Book Value Per Share (mrq)	12.50

Cash Flow

Operating Cash Flow Per Share (ytd)	0.89
Free Cash Flow (ytd)	114.04M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Bio-Techne Corp

Trade With A Regulated Broker